Loading...

TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Capital Structure Changes 8-K Filing

TV P

TV

TEVA PHARMACEUTICAL INDUSTRIES LTD

(TEVA)

2025 8-K

Credit Agreement Update

Financial Results Update

Financial Statements

Debt Restructuring

Equity Offerings

Financial Statements

Financial Results

Board Appointment

Q3 Financial Results

Financial Results Announcement

Agreement with Israeli Tax ...

Annual Meeting Voting Results

Departure and Appointment o...

Financial Results Announcement

Change in Reporting Segments

Financial Results Announcement

Financial Results Announcement

Collaboration with Sanofi

Departure and Appointment

Entry into a Material Defin...

Appointment of Director

Financial Results Announcement

Annual Meeting Voting Results

Settlement Agreement for Op...

Resignation of Director

Financial Results

External Links:

On May 20, 2025, Teva Pharmaceutical Industries announced a €1 billion and $1.2 billion offering of Senior Notes due between 2030 and 2032, with the sale expected to close on May 28, 2025.

AI Assistant

TEVA PHARMACEUTICAL INDUSTRIES LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.